Literature DB >> 76846

Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?

R S Brown, I M Jackson, S L Pohl, S Reichlin.   

Abstract

The prevalence of serum thyroid-stimulating immunoglobulins (T.S.I.) in a variety of thyroid diseases was determined in 96 patients and 35 normal controls. Significantly elevated levels of T.S.I. were found not only in patients with Graves' disease and Hashimoto's thyroiditis but also in those with non-toxic and toxic multinodular goitre, whereas patients with a single autonomously functioning thyroid nodule, with subacute thyroiditis, and with "hyperthyroiditis" had levels which did not differ from those in the controls. We postulate that non-toxic multinodular goitre, like Graves' disease, may result from increased circulating T.S.I., which in some cases may be present in sufficient concentration to cause thyrotoxicosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 76846     DOI: 10.1016/s0140-6736(78)90682-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Status of antithyroid antibodies in Bangladesh.

Authors:  M A Hasanat; M A Rumi; M N Alam; K N Hasan; M Salimullah; M A Salam; M Fariduddin; H Mahtab; A K Khan
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

2.  TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidism.

Authors:  G Schernthaner; H Ludwig; H Schleusener; R Finke; P Kotulla; W R Mayr
Journal:  Experientia       Date:  1979-10-15

3.  Plummer's disease: localized thyroid autonomy.

Authors:  J D Wiener
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

4.  Antibodies to the thyroid gland and to the thyrotrophin receptor in African and Indian thyrotoxic patients.

Authors:  R K Desai; I Jialal; M A Omar; M C Rajput; S M Joubert
Journal:  Postgrad Med J       Date:  1986-09       Impact factor: 2.401

5.  Interference of thyroglobulin in TSab detection by radio-receptor assay.

Authors:  G F Fenzi; L Bartalena; E Macchia; F Monzani; M Checchi
Journal:  J Endocrinol Invest       Date:  1979 Apr-Jun       Impact factor: 4.256

6.  Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.

Authors:  K Kasagi; R Takeuchi; T Misaki; T Kousaka; S Miyamoto; Y Iida; J Konishi
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

7.  Pathogenesis of heterogeneity in human multinodular goiter. A study on growth and function of thyroid tissue transplanted onto nude mice.

Authors:  H J Peter; H Gerber; H Studer; S Smeds
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

8.  10 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb).

Authors:  J Hensen; P Kotulla; R Finke; K Badenhoop; K Koppenhagen; H Meinhold; H Schleusener
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

9.  Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis.

Authors:  P Dandona; N J Marshall; S P Bidey; A Nathan; C W Havard
Journal:  Br Med J       Date:  1979-02-10

10.  Detection of thyroid-stimulating antibodies in thyroid diseases, employing rat thyroid fragment perifusion.

Authors:  J R Attali; P Valensi; D Darnis; C Weisselberg; J Sebaoun
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.